SecBot SecBot

OM

Outset Medical, Inc.
Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. DE· CIK 0001484612 Healthcare & Medical Devices
$4.07 −0.03 (−0.85%)
Oct 26 4:00 PM ET · prev $4.10
Market cap
$78.4M
Micro cap
Median target
$7.00
+72% · range $6.00–10.00
Next earnings
Nov 9
in 14 days · EPS est. −$0.69
1 year
−71.7%
from $14.38 · Oct 27
30 days
+37.3%
from $2.96
52-week range
$2.96–14.38
−72% from high · low Sep 28
Avg volume 20D
185.1K
Oct 1 spike 980.3K
Short interest
792.7K
≈4.2% of shares · −10.9%
Days to cover
5.9
at average volume
Insider net
+$708.0K
1 buyer · 4 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 1 bearish · 1 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/4 ·Next Earnings date, Nov 9, 2026
Strongest BULLISH BML Investment Partners, L.P. filed an amended Schedule 13G disclosing a 14.7% passive stake in Outset…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $870.3K at an average $3.55. 4 insiders sold $162.2K. Price is 14% above their cost.

  • InstitutionsMIXED

    Q2 2026: 15 added (0 new), 11 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.617 → −$0.690 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest −10.9% to 792.7K shares. 5.9 days to cover, ≈4.2% of shares.

  • TrendUPTREND

    9% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BANK OF AMERICA CORP /DE/TRIM665,847$2.9M
BlackRock, Inc.TRIM418,211$1.8M
Assenagon Asset Management S.A.TRIM339,438$1.5M
GEODE CAPITAL MANAGEMENT, LLCTRIM204,652$884.5K
GOLDMAN SACHS GROUP INCADD173,460$749.3K
JANE STREET GROUP, LLCDOUBLED139,197$601.3K
STATE STREET CORPNEAR_EXIT81,206$350.8K
SUSQUEHANNA INTERNATIONAL GROUP, LLPDOUBLED81,023$350.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Feb 2026
12-month targets · 3 analysts

Price is below the lowest target. Median implies +72%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Feb 12, 2026BTIG
MAINTAIN
MAINTAINBuy
Jan 7, 2026Stifel
MAINTAIN
MAINTAINBuy
Dec 16, 2025BTIG
REITERATE
REITERATEBuy
Nov 11, 2025Stifel
MAINTAIN
MAINTAINBuy
Nov 11, 2025RBC Capital
MAINTAIN
MAINTAINSector Perform
Nov 11, 2025BTIG
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$870.3K
bought · 1 insider
$162.2K
sold · 4 insiders
+14.4%
vs their $3.55 cost
DateInsiderTypeValue
Oct 2, 2026
Leonard Braden Michael
10%+ Owner
BUY$64.2K
Oct 1, 2026
Leonard Braden Michael
10%+ Owner
BUY$806.0K
Aug 17, 2026
Trigg Leslie
Chair and CEO
SELL$15.1K
Aug 17, 2026
Brottem John L.
General Counsel
SELL$11.6K
Aug 17, 2026
Gaeta Renee
Chief Financial Officer
SELL$19.9K
Jun 26, 2026
Trigg Leslie
Chair and CEO
AWARD99,160 sh
Jun 26, 2026
Gaeta Renee
Chief Financial Officer
AWARD71,630 sh
Jun 26, 2026
Brottem John L.
General Counsel
AWARD59,830 sh

Earnings setup

Estimates
Nov 9
reports in 14 days
−$0.69
EPS estimate, this quarter
−12%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.69-$0.77–-$0.64+0.5%$31.4M
Next Q🔒 Fresh data, subscribers only
Current FY-$3.08-$3.15–-$3.02+0.1%$126.0M
Next FY-$2.29-$2.47–-$2.15+0.0%$139.1M

Short side

FINRA· Sep 30, 2026
792,696
shares short
-10.9%
vs prior settlement
5.9
days to cover
≈4.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 21, 2026 SEC
Outset Medical, Inc. announced it will report its Q3 2026 results on November 4, 2026.
PRESS-RELEASE — Impact 1/10
Oct 21, 2026 Earnings
Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Outset Medical will report Q3 2026 financial results on November 4, 2026 after the market close....
Oct 6, 2026 SEC
BML Investment Partners, L.P. filed an amended Schedule 13G disclosing a 14.7% passive stake in Outset Medical, Inc…
SC 13G/A — Impact 5/10
Oct 2, 2026 Insider
Leonard Braden Michael bought 16,575 shares
10%+ Owner @ $3.88 ($64.2K)
Oct 1, 2026 Insider
Leonard Braden Michael bought 228,334 shares
10%+ Owner @ $3.53 ($806.0K)
Aug 28, 2026 SEC
Outset Medical disclosed that General Counsel John Brottem will depart on September 11, 2026, to pursue other…
8-K — Impact 2/10
Aug 17, 2026 Insider
Trigg Leslie sold 3,437 shares
Chair and CEO @ $4.39 ($15.1K)
Jun 30, 2026 Inst.
BANK OF AMERICA CORP — TRIM
665,847 shares ($2.9M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 9, 2026
Earnings date
OM Q3 2026 Earnings Scheduled — 2026-11-09
Recent
Oct 21, 2026
Earnings
Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Outset Medical will report Q3 2026 financial results on November 4, 2026 after the market close....
Aug 6, 2026
Earnings
Outset Medical Reports Second Quarter 2026 Results
Outset Medical reported Q2 2026 results and reiterated full year revenue guidance.
Aug 6, 2026
Earnings date
OM Q2 2026 Earnings Scheduled — 2026-08-06
Jul 6, 2026
FDA
Outset Medical, Inc. (NASDAQ: OM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements, Over $50 Million in Insider Sales
SAN FRANCISCO, July 6, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Outset Medical, Inc. (NASDAQ: OM) investors that the firm is…
Jul 2, 2026
Press release
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Outset announces inducement grant.

SecBot reports

9 filings · 1 press release · 1 bullish · 1 bearish · 7 neutral
All OM filing & press-release reports (10)